An ME/CFS Expert Helps a Long-COVID Patient Recover
- Condition
- Long COVID
- At worst
- Moderate (mostly housebound)
- Ill for
- 2.5 years
- Published
- Apr 2023
Summary
A nineteen-year-old developed POTS and mast cell symptoms after a mild PCR-confirmed COVID infection, leaving him with a wellness score of 45 out of 100 and out of in-person classes for about fifteen months. Under Dr Peter Rowe at Johns Hopkins he was treated with methylphenidate and clonidine for POTS, fexofenadine, famotidine, cromolyn and quercetin for mast cell activation, plus low-dose naltrexone, escitalopram and graduated physical therapy. Two to three years after onset he had returned to near-complete health and competed in an eight-kilometre cross-country race, though slower than before.
What they credit
Credits Low-dose naltrexone, POTS medication, Antihistamines & MCAS, Diet, Supplements, Baicalein and quercetin, H1 antihistamines, H2 blockers (famotidine, cimetidine), Ketotifen / cromolyn, Low-dose naltrexone, SSRIs and antidepressants, Stimulants (methylphenidate, amphetamines).
Symptoms mentioned
Symptoms: Mast cell (MCAS) & allergies, POTS & dysautonomia.
Similar stories
-
List of ME/CFS Recovery and Improvement Stories (page 14 discussion)
ixikd2025 credited a broad, kitchen-sink regimen spanning stimulant, mitochondrial, antihistamine/MCAS, and lifestyle interventions (meditation, running, acupuncture) for significant improvement. With so many concurrent changes, no single component could be…
-
Several long-COVID patients report improvements from antihistamines (Emeline)
Trialed loratadine 10mg twice daily plus famotidine 40mg once daily over a 34-day self-trial, more than four years into her illness; she initially dosed in the morning, then moved the famotidine to the evening after two weeks, which subjectively felt like a…
-
Several long-COVID patients report improvements from antihistamines (Rich D)
Tried Singulair (montelukast), which produced significant, though not huge, improvement within about a week, while Pepcid (famotidine) and Zyrtec (cetirizine) had no effect for them. They suggest antihistamines are most useful for long-COVID patients who…
-
Impact of extended-course Paxlovid in established Long COVID (Case 2)
Case 2, a 45-year-old woman about 11 months into Long COVID with orthostatic intolerance, tachycardia, short-term memory loss, word-finding trouble, fatigue, PEM and MCAS symptoms, took a 15-day extended course of Paxlovid (nirmatrelvir/ritonavir) in…